These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34094689)

  • 1. Association between the polygenic liabilities for prostate cancer and breast cancer with biochemical recurrence after radical prostatectomy for localized prostate cancer.
    Wang SH; Huang SP; Pan YJ; Hsiao PC; Li CY; Chen LC; Yu CC; Huang CY; Lin VC; Lu TL; Bao BY
    Am J Cancer Res; 2021; 11(5):2331-2342. PubMed ID: 34094689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation.
    Zhao F; Hao Z; Zhong Y; Xu Y; Guo M; Zhang B; Yin X; Li Y; Zhou X
    BMC Cancer; 2021 Feb; 21(1):194. PubMed ID: 33632172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
    Cheng Y; Wu L; Xin J; Ben S; Chen S; Li H; Zhao L; Wang M; Cheng G; Du M
    J Transl Med; 2024 Apr; 22(1):366. PubMed ID: 38632662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population.
    Akdeniz BC; Mattingsdal M; Dominguez-Valentin M; Frei O; Shadrin A; Puustusmaa M; Saar R; Sõber S; Møller P; Andreassen OA; Padrik P; Hovig E
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of polygenic risk score for prostate cancer incidence and prognosis in the Han Chinese.
    Hung SC; Chang LW; Hsiao TH; Wei CY; Wang SS; Li JR; Chen IC
    Sci Rep; 2024 Sep; 14(1):20453. PubMed ID: 39227454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation.
    Tsoulos N; Papadopoulou E; Agiannitopoulos K; Grigoriadis D; Tsaousis GN; Bouzarelou D; Gogas H; Troupis T; Venizelos V; Fountzilas E; Theochari M; Ziogas DC; Giassas S; Koumarianou A; Christopoulou A; Busby G; Nasioulas G; Markopoulos C
    Diagnostics (Basel); 2024 Aug; 14(16):. PubMed ID: 39202314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese.
    Chan CHT; Munusamy P; Loke SY; Koh GL; Yang AZY; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng RCH; Ong KW; Madhukumar P; Oey CL; Ho GH; Tan PH; Tan MH; Ang P; Yap YS; Lee ASG
    Oncotarget; 2018 Feb; 9(16):12796-12804. PubMed ID: 29560110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of genetic susceptibility to 16 cancers with risk of breast cancer overall and by intrinsic subtypes.
    Choi J; Jia G; Wen W; Tao R; Long J; Shu XO; Zheng W
    HGG Adv; 2022 Jan; 3(1):100077. PubMed ID: 35047862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of Risk-Stratified Breast Cancer Prevention With a Polygenic Risk Score Test in Clinical Practice.
    Padrik P; Puustusmaa M; Tõnisson N; Kolk B; Saar R; Padrik A; Tasa T
    Breast Cancer (Auckl); 2023; 17():11782234231205700. PubMed ID: 37842230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of polygenic risk information among women at increased risk of breast cancer.
    Yanes T; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Young MA; James PA
    Clin Genet; 2020 Mar; 97(3):492-501. PubMed ID: 31833054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Risk Prediction for Breast Cancer in Older Women.
    Lacaze P; Bakshi A; Riaz M; Orchard SG; Tiller J; Neumann JT; Carr PR; Joshi AD; Cao Y; Warner ET; Manning A; Nguyen-Dumont T; Southey MC; Milne RL; Ford L; Sebra R; Schadt E; Gately L; Gibbs P; Thompson BA; Macrae FA; James P; Winship I; McLean C; Zalcberg JR; Woods RL; Chan AT; Murray AM; McNeil JJ
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease.
    Bakshi A; Riaz M; Orchard SG; Carr PR; Joshi AD; Cao Y; Rebello R; Nguyen-Dumont T; Southey MC; Millar JL; Gately L; Gibbs P; Ford LG; Parnes HL; Chan AT; McNeil JJ; Lacaze P
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic Risk Score Predicts Modified Risk in
    Berga-Švītiņa E; Maksimenko J; Miklaševičs E; Fischer K; Vilne B; Mägi R
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and testing of a polygenic risk score for breast cancer aggressiveness.
    Shieh Y; Roger J; Yau C; Wolf DM; Hirst GL; Swigart LB; Huntsman S; Hu D; Nierenberg JL; Middha P; Heise RS; Shi Y; Kachuri L; Zhu Q; Yao S; Ambrosone CB; Kwan ML; Caan BJ; Witte JS; Kushi LH; 't Veer LV; Esserman LJ; Ziv E
    NPJ Precis Oncol; 2023 May; 7(1):42. PubMed ID: 37188791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Breast Cancer Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results.
    Ong SS; Ho PJ; Khng AJ; Lim EH; Wong FY; Tan BK; Lim SH; Tan EY; Tan SM; Tan VKM; Dent R; Tan TJY; Ngeow J; Madhukumar P; Hamzah JLB; Sim Y; Lim GH; Pang JS; Alcantara VS; Chan PMY; Chen JJC; Kuah S; Seah JCM; Buhari SA; Tang SW; Ng CWQ; Li J; Hartman M
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
    Robson ME; Reiner AS; Brooks JD; Concannon PJ; John EM; Mellemkjaer L; Bernstein L; Malone KE; Knight JA; Lynch CF; Woods M; Liang X; Haile RW; Duggan DJ; Shore RE; Smith SA; Thomas DC; Stram DO; Bernstein JL;
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutational profiles and germline polygenic risk scores in human cancer.
    Liu Y; Gusev A; Heng YJ; Alexandrov LB; Kraft P
    Genome Med; 2022 Feb; 14(1):14. PubMed ID: 35144655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk scores stratify breast cancer risk among women with benign breast disease.
    Sherman ME; Winham SJ; Vierkant RA; Mccauley BM; Scott CG; Schrup S; Gaudet MM; Troester MA; Pruthi S; Radisky DC; Degnim AC; Couch FJ; Bolla MK; Wang Q; Dennis J; Michailidou K; Guenel P; Truong T; Chang-Claude J; Obi N; Aronson KJ; Murphy R; Garcia-Closas M; Chanock S; Ahearn T; Yang X; Dunning AM; Mavaddat N; Pharoah PDP; Easton DF; Vachon CM
    J Natl Cancer Inst; 2024 Oct; ():. PubMed ID: 39412492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and prostate cancer risk: The interplay of polygenic risk, rare pathogenic germline variants, and family history.
    Hassanin E; May P; Aldisi R; Spier I; Forstner AJ; Nöthen MM; Aretz S; Krawitz P; Bobbili DR; Maj C
    Genet Med; 2022 Mar; 24(3):576-585. PubMed ID: 34906469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.
    Li J; Holm J; Bergh J; Eriksson M; Darabi H; Lindström LS; Törnberg S; Hall P; Czene K
    Ann Oncol; 2015 Mar; 26(3):517-22. PubMed ID: 25488685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.